ADC Offers Promising Results in Relapsed or Refractory Hodgkin Lymphoma
Good response rate with camidanlumab tesirine, although a lot of patients experienced AEs
Source: medpagetoday.com
Stay updated with breaking news from Alisonj Moskowitz. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Good response rate with camidanlumab tesirine, although a lot of patients experienced AEs
Combo regimen offers 'a new standard for front-line therapy,' researcher says